The Sentosa SQ HCV Genotyping Assay uses next-generation sequencing (NGS)-technology to deliver accurate detection of Hepatitis C Virus genotypes 1-6 and their associated subtypes as well as identification of resistance-associated substitutions (RASs).

Compared with traditional methods for HCV genotyping such as line-probe assays (LiPA), this NGS assay eliminates genotyping errors while simultaneously delivering information about RASs found in the sample

For Research Use Only. Not for use in diagnostic procedures.  

• Delivers genotyping & RAS identification accuracy in a single, efficient workflow

• Reliable, automated solution – full workflow automation combined with built-in controls give you confidence in your results

• Speeds time to next steps – simultaneously analyze genotyping and RAS-calling with minimal hands-ontime using our automated solution

• Expert assay design – multiplexed sequencing design targets key regions indicated in AASLD guidelines including genotypes 1 through 6 as well as 70 subtypes enabling discovery of potential new relationships between subtypes and novel therapeutics